Recent News

• 10.23.2025 - Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
• 10.14.2025 - Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
• 10.01.2025 - Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
• 10.01.2025 - Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
• 09.16.2025 - Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
• 09.16.2025 - Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
• 09.10.2025 - Elutia at the H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
• 09.09.2025 - Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

Recent Filings

• 10.14.2025 - 8-K Current report
• 10.14.2025 - 3 Initial statement of beneficial ownership of securities
• 10.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.14.2025 - EX-99.1 EX-99.1
• 10.07.2025 - 8-K Current report
• 10.07.2025 - EX-99.1 EX-99.1
• 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.09.2025 - 8-K Current report